INTRODUCTION
============

The definition of overactive bladder syndrome (OAB) is urinary urgency, with or without urgency urinary incontinence, which is usually accompanied by urinary frequency and nocturia in the absence of urinary tract infection or other obvious pathologies \[[@b1-inj-1836212-106]\].

OAB can be subclassified as OAB-dry or OAB-wet \[[@b2-inj-1836212-106]\], with an approximate ratio of 2 to 1 \[[@b3-inj-1836212-106]\], and the prevalence of OAB-wet increases with advancing age \[[@b4-inj-1836212-106]\]. However, the underlying pathophysiology of OAB-dry vs. OAB-wet may be different. Kuo et al. \[[@b5-inj-1836212-106]\] reported that urinary nerve growth factor levels are increased in OAB-wet but not OAB-dry. Hsiao et al. \[[@b6-inj-1836212-106]\] reported that C-reactive protein levels are increased in OAB-wet. Hashim and Abrams \[[@b7-inj-1836212-106]\] reported 44% of women with OAB-dry had detrusor overactivity (DO), while 58% of women with OAB-wet had DO. Al-Ghazo et al. \[[@b8-inj-1836212-106]\] also reported 61% of women with OAB-dry had DO, while 69.8% of women with OAB-wet had DO. It has been reported that many patients labeled as OAB-dry may actually be mild OAB-wet \[[@b2-inj-1836212-106]\].

Currently, treatments for OAB-dry vs. OAB-wet patients are nearly the same \[[@b9-inj-1836212-106]\]. Nonetheless, for intravesical injection of onabotulinumtoxinA, OAB-wet patients are associated better therapeutic efficacy \[[@b10-inj-1836212-106]\]. Balzarro et al. \[[@b11-inj-1836212-106]\] also confirmed the efficacy of intravesical injection of onabotulinumtoxinA for treatment of women with OAB-wet. An Urgency Severity Scale score of 4 is OAB-wet, and it was reported that OAB patients with high Urgency Severity Scale score were associated with better therapeutic efficacy after solifenacin treatment \[[@b12-inj-1836212-106],[@b13-inj-1836212-106]\].

Different underlying pathophysiologies may benefit from different treatments. We are interested in whether there is a different underlying pathophysiology in OAB-dry vs. OAB-wet. Comparison of clinical and urodynamic variables between OAB-dry and OAB-wet might be helpful for understanding the underlying pathophysiology. Thus, the aim of this study was to identify clinical and urodynamic factors predicting OAB-wet, compared with OAB-dry.

MATERIALS AND METHODS
=====================

Between September 2007 and September 2013, the medical records of consecutive 623 women with OAB who completed a 3-day bladder diary and underwent urodynamic studies at the urogynecologic outpatient clinics of the Department of Obstetrics and Gynecology of a medical center were retrospectively reviewed. OAB was defined as the presence of urinary urgency, with or without urgency incontinence, which is usually accompanied by urinary frequency and nocturia \[[@b1-inj-1836212-106]\]. This study was approved by the Research Ethics Committee in our hospital. Besides, this study has been registered at ClinicalTrials.gov.

The following inclusion criteria were used: (1) women at least 18 years old, who had at least a 3-month history of OAB symptoms, including urgency, urinary frequency, nocturia, or urge incontinence and (2) an average of ≥8 micturitions in 24 hours \[[@b14-inj-1836212-106],[@b15-inj-1836212-106]\]. The exclusion criteria included dominant symptoms with stress urinary incontinence, regular urethral catheterization or intermittent self-catheterization, urinary tract infection or chronic inflammation in the previous 2 weeks, bladder calculus, neurogenic bladder due to radical hysterectomy or injury of central nervous system, and a history of pelvic radiotherapy or a preexisting malignant pelvic tumor. In the study of Stewart et al. \[[@b16-inj-1836212-106]\], OAB-dry was defined as patients who had ≥4 urgency episodes in the past 4 weeks; and OAB-wet was defined as patients who complained of ≥3 urgency incontinence episodes in the past 4 weeks. However, in our study, OAB-wet was diagnosed in patients who complained of at least one episode of urgency incontinence in the previous month; otherwise, OAB-dry was diagnosed.

The medical history, including information such as age and parity, was reviewed for each patient. The urodynamic assessment included uroflowmetry, filling cystometry with 35°C distilled water at a rate of 60 mL/sec, a pressure flow study, and the stress urethral pressure profile with patient in sitting position \[[@b17-inj-1836212-106]\]. Additionally, a 20-minute pad test for each woman was performed \[[@b18-inj-1836212-106],[@b19-inj-1836212-106]\]. DO was defined as evidence of spontaneous detrusor contractions occurring during bladder filling or an uninhibited detrusor contraction occurring at a cystometric capacity that usually results in voiding \[[@b20-inj-1836212-106]\]. If patients had a strong desire to void at a volume less than 300 mL, they were considered to have bladder oversensitivity \[[@b21-inj-1836212-106]\]. Functional bladder outlet obstruction (BOO) was defined as uroflowmetry results \<15-mL/sec maximal flow rate (Qmax) and \>20-cm H~2~O detrusor pressure at maximal flow rate (PdetQmax) measured via voiding cystometry and without a known anatomic cause of obstruction \[[@b22-inj-1836212-106],[@b23-inj-1836212-106]\].

Multichannel urodynamic equipment (Life-Tech, Houston, TX, USA) with computer analysis and Urovision (Urolab Janus System V, Houston) was used. All terminology conformed to the standards recommended by the International Continence Society and Urodynamic Society \[[@b1-inj-1836212-106]\]. All procedures were performed by an experienced technician, and the data were interpreted by a single observer to avoid interobserver variability.

STATA ver. 11.0 (Stata Corp., College Station, TX, USA) was used for statistical analyses. The chi-square test and Wilcoxon rank-sum test were used as appropriate. A P-value of less than 0.05 was considered statistically significant. A multivariable logistic regression analysis was performed using variables that had a P-value \<0.05 from the univariate analysis \[[@b24-inj-1836212-106]\].

RESULTS
=======

One hundred twenty-seven women with OAB-wet and 496 women with OAB-dry were enrolled in this study. Comparisons of age, parity, pad weights, and urodynamic and bladder diary parameters between the OAB-wet and OAB-dry groups are shown in [Tables 1](#t1-inj-1836212-106){ref-type="table"} and [2](#t2-inj-1836212-106){ref-type="table"}. Age and parity were significantly different between the OAB-wet and OAB-dry groups ([Table 1](#t1-inj-1836212-106){ref-type="table"}). After adjusting for age and parity, we found that Qmax, voided volume, PdetQmax, urodynamic stress incontinence (USI), pad weight, urgency episodes, incontinence episodes, and bladder contractility index (i.e.,=PdetQmax+5×Qmax) \[[@b25-inj-1836212-106]\] were significantly different between the OAB-wet and OAB-dry groups ([Tables 1](#t1-inj-1836212-106){ref-type="table"}, [2](#t2-inj-1836212-106){ref-type="table"}).

Because pad weight was highly correlated to USI (Spearman rho=0.88, P\<0.0001), pad weight was not included in the multivariable analysis ([Table 2](#t2-inj-1836212-106){ref-type="table"}). In addition, incontinence episodes \>0 predicted OAB-wet perfectly, therefore, we excluded the variable "incontinence episodes" in the multivariable analysis ([Table 2](#t2-inj-1836212-106){ref-type="table"}). In model 1, using age, parity and the other statistically significant adjusted variables shown in [Tables 1](#t1-inj-1836212-106){ref-type="table"} and [2](#t2-inj-1836212-106){ref-type="table"}, a multivariable logistic regression was performed to predict OAB-wet ([Table 3](#t3-inj-1836212-106){ref-type="table"}). Age (odds ratio \[OR\],1.05; P\<0.001), Qmax (OR, 1.06; P\<0.001), voided volume (OR, 0.996; P=0.001), PdetQmax (OR, 1.02; P=0.003), USI (OR, 1.78; P=0.01), and urgency episodes (OR, 1.04; P\<0.001) were independent predictors for OAB-wet vs. OAB-dry ([Table 3](#t3-inj-1836212-106){ref-type="table"}). In model 2, bladder contractility index was included as a variable for multivariable logistic regression to predict OAB-wet, instead of using Qmax and PdetQmax as variables ([Table 3](#t3-inj-1836212-106){ref-type="table"}); bladder contractility index (OR, 1.012; P\<0.0001) was found to be an independent predictor for OAB-wet ([Table 3](#t3-inj-1836212-106){ref-type="table"}).

DISCUSSION
==========

Compared with OAB-dry, a smaller voided volume (OR, 0.996) and higher urgency episodes (OR, 1.04) were found to be predictors of OAB-wet ([Table 3](#t3-inj-1836212-106){ref-type="table"}). Al-Zahrani and Gajewski \[[@b26-inj-1836212-106]\] reported that as overactive bladder symptoms increase in severity, female patients tend to have a smaller bladder capacity. Urgency is the core symptom of female OAB \[[@b27-inj-1836212-106]\], and Giarenis et al. \[[@b28-inj-1836212-106]\] found a negative correlation between urgency episodes and bladder capacity in women with idiopathic DO. Thus, together with our findings, the speculation of OAB-wet as a severe form of OAB seems reasonable.

Cho et al. \[[@b29-inj-1836212-106]\] reported similar Qmax (mean: 15.3 mL/sec vs. 15.0 mL/sec, P=0.759) and PdetQmax (mean: 31.0 cm H~2~O vs. 31.4 cm H~2~O, P=0.862) between the OAB-dry and OAB-wet patients. In our study, high Qmax (OR, 1.06) and high PdetQmax (OR, 1.01) were identified as novel predictors for OAB-wet ([Table 3](#t3-inj-1836212-106){ref-type="table"}). Furthermore, bladder contractility index (i.e.,=PdetQmax +5×Qmax) \[[@b25-inj-1836212-106]\] (OR, 1.012, P\<0.001) is an independent predictor for OAB-wet ([Table 3](#t3-inj-1836212-106){ref-type="table"}). Thus, our findings of high Qmax, high PdetQmax, and high bladder contractility index as predictors of OAB-wet may hint that the bladder contractility is better for OAB-wet, compared with OAB-dry.

Old age (OR, 1.04) is another predictor for OAB-wet ([Table 3](#t3-inj-1836212-106){ref-type="table"}). Chen et al. \[[@b4-inj-1836212-106]\] reported that the prevalence of OAB-wet increased with advancing age. Tyagi et al. \[[@b30-inj-1836212-106]\] reported a significant association between OAB symptoms and age (OR,1.12). Hung et al. \[[@b27-inj-1836212-106]\] also reported that women with OAB-wet had a greater average age.

In our study, USI was a predictor for OAB-wet, and women with OAB-wet had a higher incidence of coexistent USI, vs. OAB-dry (54.3% vs. 33.5%, P\<0.001) ([Table 1](#t1-inj-1836212-106){ref-type="table"}). From the ambulatory urodynamic monitoring data of Dokmeci et al. \[[@b31-inj-1836212-106]\], the rate of stress urinary incontinence in OAB-wet also had a trend to be higher than OAB-dry (72.5% vs. 52.8%, P=0.075). From the above, if the clinical works for treating OAB-wet resulted in poor therapeutic response, then combined treatment for the coexistence of USI might be considered in clinical practice.

Nowadays, treatments for OAB-wet vs. OAB-dry patients are nearly the same \[[@b9-inj-1836212-106]\]. However, from our results, OAB-wet women have different clinical presentations, such as greater severity in symptoms, greater bladder contractility and higher coexistent USI rate, compared with OAB-dry ([Table 3](#t3-inj-1836212-106){ref-type="table"}). Thus, pretreatment assessment or treatment strategies might be different for OAB-wet vs. OAB-dry. For example, urodynamic studies to unmask USI might be indicated for OAB-wet women with poor response to pharmacotherapy \[[@b32-inj-1836212-106]\]; higher starting dose for the treatment of OAB might be more suitable for OAB-wet; for the indication of intravesical injection of onabotulinumtoxinA \[[@b10-inj-1836212-106],[@b32-inj-1836212-106]\], OAB-wet patients should be more suitable than OAB-dry \[[@b10-inj-1836212-106]\]. Future prospective clinical studies should be performed to find the most suitable treatment strategy for OAB-wet vs. OAB-dry patients.

The retrospective design of this study was a limitation; however, the large sample size should make our data reliable. Besides, we do not have the posttreatment data. Further studies may be performed to elucidate post-treatment differences between OAB-dry and OAB-wet. In addition, we do not have long-term follow-up data; future long-term follow-up studies may be performed to clarify the relationship between OAB-dry and OAB-wet.

In conclusion, a smaller bladder capacity and more frequent urgency episodes were predictors of OAB-wet, and the above findings indicate that OAB-wet and OAB-dry might be a continuum of OAB. Old age, high Qmax, high PdetQmax, and USI were also independent predictors for OAB-wet, and the above results indicate that OAB-wet and OAB-dry have partially different clinical and urodynamic features. Further studies may be performed to elucidate whether different treatment strategies between OAB-dry and OAB-wet could improve treatment efficacy.
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###### 

Comparisons of the urodynamic parameters between the OAB-wet and OAB-dry groups (n=623)

  Variable                                                           OAB-wet (n=127)   OAB-dry (n=496)   P-value^[a)](#tfn1-inj-1836212-106){ref-type="table-fn"}^   Coefficient or OR (95% CI) of OAB-wet^[b)](#tfn2-inj-1836212-106){ref-type="table-fn"}^   P-value^[b)](#tfn2-inj-1836212-106){ref-type="table-fn"}^
  ------------------------------------------------------------------ ----------------- ----------------- ----------------------------------------------------------- ----------------------------------------------------------------------------------------- -----------------------------------------------------------
  Age (yr)                                                           61.8±13.4         55.3±13.0         \<0.001                                                     \-                                                                                        \-
  Parity                                                             3.0±1.8           2.6±1.6           0.005                                                       \-                                                                                        \-
  Qmax (mL/sec)                                                      20.9±11.3         19.2±8.5          0.38                                                        2.00 (0.18--3.81)                                                                         0.03
  Voided volume (mL)                                                 245±129           281±119           0.004                                                       -25.2 (-49.0 to -1.4)                                                                     0.04
  Postvoid residual (mL)                                             77±64             70±59             0.08                                                        5.4 (-6.6 to 17.4)                                                                        0.38
  Voiding time (sec)                                                 54.8±78.0         56.2±52.2         0.001                                                       0.24 (-22.5 to 11.8)                                                                      0.98
  Strong desire to void (mL)                                         233±102           242±70            0.04                                                        -5.0 (-20.5 to 10.5)                                                                      0.53
  PdetQmax (cm H~2~O)                                                35.6±21.9         31.3±19.0         0.04                                                        6.0 (1.9--10.1)                                                                           0.004
  MUCP (cm H~2~O)                                                    63.3±29.5         73.3±32.2         0.002                                                       -2.0 (-7.5 to 3.4)                                                                        0.47
  Functional profile length (cm)                                     3.1±0.8           3.1±0.9           0.98                                                        -0.01 (-0.18 to 0.17)                                                                     0.95
  PTR at MUP (%)                                                     89.8±29.8         95.4±31.4         0.08                                                        -5.1 (-11.4 to 1.1)                                                                       0.11
  Detrusor overactivity                                              44 (35)           129 (26)          0.053                                                       1.4 (0.9--2.2)                                                                            0.12
  Bladder oversensitivity                                            101 (80)          387 (78)          0.71                                                        1.0 (0.6--1.7)                                                                            0.93
  Urodynamic stress incontinence                                     69 (54)           165 (33)          \<0.001                                                     2.1 (1.4--3.1)                                                                            0.001
  Functional BOO^[c)](#tfn3-inj-1836212-106){ref-type="table-fn"}^   25 (22)           91 (21)           0.95                                                        1.06 (0.64--1.79)                                                                         0.80
  Pad weight (g)                                                     16.8±30.7         3.7±14.9          \<0.001                                                     11.7 (7.9--15.5)                                                                          \<0.001
  BOOI                                                               -6.6±2.7          -8.2±1.3          0.69                                                        2.5 (-3.2 to 8.2)                                                                         0.38
  Bladder contractility index                                        141.2±63.4        129.8±46.7        0.21                                                        14.8 (4.1--25.4)                                                                          0.007

Values are expressed as the mean±standard deviation or number (%) unless otherwise indicated.

OAB, overactive bladder syndrome; OR, odds ratio; CI, confidence interval; Qmax, maximal flow rate; PdetQmax, detrusor pressure at maximal flow during voiding cystometry; MUCP, maximal urethral closure pressure; PTR, pressure transmission ratio; MUP, maximal urethral pressure; BOO, bladder outlet obstruction; BOOI, bladder outlet obstruction index.

By the Wilcoxon rank-sum test or chi-square test.

Age and parity were significantly different between the OAB-wet and OAB-dry groups. The coefficient or odds ratio of OAB-wet (OAB-wet=1; OAB-dry=0) is derived from linear or logistic regression analysis of the value in each variable adjusted for age and parity to reveal the impact of OAB-wet on each variable, compared with OAB-dry.

Only 539 cases (OAB-wet, n=115; OAB-dry, n=424) had measurable PdetQmax data.

###### 

Comparisons of the bladder diary parameters between the OAB-wet and OAB-dry groups (n=623)

  Variable                         OAB-wet (n=127)   OAB-dry (n=496)   P-value^[a)](#tfn4-inj-1836212-106){ref-type="table-fn"}^   Coefficient (95% CI) of OAB-wet^[b)](#tfn5-inj-1836212-106){ref-type="table-fn"}^   P-value^[b)](#tfn5-inj-1836212-106){ref-type="table-fn"}^
  -------------------------------- ----------------- ----------------- ----------------------------------------------------------- ----------------------------------------------------------------------------------- -----------------------------------------------------------
  DVVmax (72 hr)                   359±161           356±166           0.68                                                        5.8 (-26.8 to 38.3)                                                                 0.73
  Urgency episodes (72 hr)         11.5±11.1         7.2±11.8          \<0.001                                                     4.6 (2.3--6.9)                                                                      \<0.001
  Incontinence episodes (72 hr)    6.4±7.0           0±0               \<0.001                                                     6.3 (5.7--6.9)                                                                      \<0.001
  Daytime frequency (72 hr)        29.1±10.6         31.5±16.3         0.39                                                        -1.2 (-4.2 to 1.8)                                                                  0.42
  Nocturia (72 hr)                 4.6±4.4           4.7±4.0           0.38                                                        -0.3 (-1.1 to 0.5)                                                                  0.49
  Total voided volume (mL/72 hr)   5,490±2,478       5,487±2,067       0.51                                                        51.3 (-378.4 to 481.1)                                                              0.82
  Total water intake (mL/72 hr)    4,845±2,063       5,039±1,984       0.29                                                        -105.8 (-502.7 to 291.10)                                                           0.60

Values are expressed as the mean±standard deviation unless otherwise indicated.

OAB, overactive bladder syndrome; CI, confidence interval; DVVmax, maximal daytime voided volume excluding the morning void derived from 3-day bladder diaries.

Wilcoxon rank-sum test or chi-square test.

The coefficient of OAB-wet (OAB-wet=1; OAB-dry=0) is derived from linear regression analysis of the value in each variable adjusted for age and parity.

###### 

Factors predicting women with OAB-wet using univariate and multivariable logistic regressi

  Variable                                                                        Univariate             Multivariate^[a)](#tfn6-inj-1836212-106){ref-type="table-fn"}^, model 1   Multivariate^[a)](#tfn6-inj-1836212-106){ref-type="table-fn"}^, model 2                                    
  ------------------------------------------------------------------------------- ---------------------- ------------------------------------------------------------------------- ------------------------------------------------------------------------- --------- ---------------------- ---------
  Age                                                                             1.04 (1.02--1.060)     \<0.001                                                                   1.05 (1.03--1.08)                                                         \<0.001   1.05 (1.03--1.08)      \<0.001
  Parity                                                                          1.02 (1.06--1.34)      0.004                                                                     0.92 (0.77--1.10)                                                         0.36      0.92 (0.77--1.10)      0.37
  Qmax                                                                            1.02 (1.00--1.04)      0.07                                                                      1.06 (1.03--1.09)                                                         \<0.001   \-                     \-
  Voided volume                                                                   0.997 (0.996--0.999)   0.003                                                                     0.996 (0.993--0.998)                                                      0.001     0.995 (0.993--0.998)   \<0.001
  PdetQmax                                                                        1.01 (1.00--1.02)      0.04                                                                      1.02 (1.01--1.03)                                                         0.003     \-                     \-
  Urodynamic stress incontinence                                                  2.39 (1.61--3.55)      \<0.001                                                                   1.78 (1.13--2.82)                                                         0.01      1.75 (1.11--1.05)      0.02
  Urgency episodes                                                                1.03 (1.01--1.04)      \<0.001                                                                   1.04 (1.02--1.05)                                                         \<0.001   1.04 (1.02--1.05)      \<0.001
  Bladder contractility index^[b)](#tfn7-inj-1836212-106){ref-type="table-fn"}^   1.004 (1.000--1.008)   0.04                                                                      \-                                                                        \-        1.012 (1.007--1.018)   \<0.001

Model 1: Using age, parity, and the other statistically significant adjusted variables shown in Tables 1 and 2, but not using bladder contractility index as a variable, a multivariable logistic regression was performed to predict OAB-wet; model 2: Bladder contractility index was included as a variable for multivariable logistic regression to predict OAB-wet, instead of using Qmax and PdetQmax as variables.

OAB, overactive bladder syndrome; CI, confidence interval; Qmax, maximal flow rate; PdetQmax, detrusor pressure at maximal flow during voiding cystometry.

Multivariate logistic regression was performed using the significant variables in Tables 1 and 2. However, we excluded the variable of incontinence episodes in the model because incontinence episodes \>0 predicts OAB-wet perfectly, and women with incontinence episodes \>0 were defined to be in the OAB-wet group.

Bladder contractility index=PdetQmax+5×Qmax.
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